Vacina da COVID-19 (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vacina da COVID-19" in Galician language version.

refsWebsite

Global rank Galician rank

17doi.org

2^nd place

7^th place

16web.archive.org

1^st place

14nih.gov

4^th place

6^th place

7clinicaltrials.gov

5,225^th place

7,257^th place

4worldcat.org

5^th place

11^th place

3theguardian.com

12^th place

64^th place

2cepi.net

low place

2reuters.com

49^th place

168^th place

2cnn.com

28^th place

97^th place

2scmp.com

362^nd place

2,734^th place

2bizjournals.com

407^th place

1,497^th place

1sciencealert.com

5,043^rd place

low place

1nature.com

234^th place

113^th place

1milkeninstitute.org

low place

1fiercepharma.com

low place

1trialsitenews.com

low place

1nhs.uk

1,989^th place

2,769^th place

1springer.com

274^th place

251^st place

1harvard.edu

18^th place

38^th place

1clinicaltrialsarena.com

low place

1marketwatch.com

1,303^rd place

4,107^th place

1ctvnews.ca

768^th place

4,409^th place

1cmaj.ca

low place

1triblive.com

2,497^th place

low place

1thelancet.com

2,393^rd place

2,657^th place

1vaccines.gov

low place

1fda.gov

447^th place

749^th place

1sciencemag.org

857^th place

242^nd place

1bio.org

low place

1cbc.ca

115^th place

408^th place

1archive.today

14^th place

30^th place

1nasdaq.com

2,740^th place

low place

1preprints.org

low place

1romania-actualitati.ro

low place

1globenewswire.com

2,614^th place

low place

1stlpublicradio.org

low place

1defense.gov

1,038^th place

7,334^th place

1indiatimes.com

17^th place

440^th place

1canada.ca

1,712^th place

5,656^th place

1globalnews.ca

985^th place

6,114^th place

1businesswire.com

615^th place

3,718^th place

1europa.eu

68^th place

75^th place

1techcrunch.com

187^th place

913^th place

1shelstonip.com

low place

1takisbiotech.it

low place

1usnews.com

634^th place

1,964^th place

1imperial.ac.uk

7,025^th place

8,653^rd place

1consalud.es

low place

1cnet.com

272^nd place

782^nd place

1mybluemix.net

low place

1c3.ai

low place

1nytimes.com

7^th place

32^nd place

1politifact.com

3,208^th place

low place

1factcheck.org

7,075^th place

low place

archive.today

"Saskatchewan lab joins global effort to develop coronavirus vaccine". CBC News. The Canadian Press. 24 de xaneiro de 2020. Arquivado dende o orixinal o 25 de xaneiro de 2020. Consultado o 25 de xaneiro de 2020.

bio.org

"Clinical Development Success Rates 2006-2015" (PDF). BIO Industry Analysis. xuño de 2016. Arquivado dende o orixinal (PDF) o 12 de setembro de 2019. Consultado o 06 de abril de 2020.

bizjournals.com

Gilgore, Sara (18 de marzo de 2020). "Emergent BioSolutions dives into another coronavirus vaccine effort". Washington Business Journal. Consultado o 18 de marzo de 2020.
Gilgore, Sara (10 de marzo de 2020). "Novavax's coronavirus vaccine program is getting some help from Emergent BioSolutions". Washington Business Journal (Charlotte, NC: American City Business Journals).

businesswire.com

"Medicago announces production of a viable vaccine candidate for COVID-19". Business Wire. 2020-03-12. Consultado o 2020-03-24.

c3.ai

"C3.ai, Microsoft, and Leading Universities Launch C3.ai Digital Transformation Institute". 2020-03-26. Consultado o 2020-03-28.

canada.ca

"Government of Canada funds 49 additional COVID-19 research projects – Details of the funded projects". Government of Canada. 23 de marzo de 2020. Consultado o 23 de marzo de 2020.

cbc.ca

"Saskatchewan lab joins global effort to develop coronavirus vaccine". CBC News. The Canadian Press. 24 de xaneiro de 2020. Arquivado dende o orixinal o 25 de xaneiro de 2020. Consultado o 25 de xaneiro de 2020.

cepi.net

"CEPI welcomes UK Government's funding and highlights need for $2 billion to develop a vaccine against COVID-19". Coalition for Epidemic Preparedness Innovations, Oslo, Norway. 6 de marzo de 2020. Consultado o 23 de marzo de 2020.
"CEPI collaborates with the Institut Pasteur in a consortium to develop COVID-19 vaccine". Coalition for Epidemic Preparedness Innovations. 19 de marzo de 2020. Consultado o 23 de marzo de 2020.

clinicaltrials.gov

Número do ensaio clínico NCT04341389 para "A Phase II Clinical Trial to Evaluate the Recombinant Novel Coronavirus Vaccine (Adenovirus Vector)" en ClinicalTrials.gov
Número do ensaio clínico NCT04313127 para "A Phase I Clinical Trial in 18-60 Adults" en ClinicalTrials.gov
Número do ensaio clínico NCT04324606 para "A Study of a Candidate COVID-19 Vaccine (COV001)" en ClinicalTrials.gov
Número do ensaio clínico NCT04283461 para "Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis SARS CoV-2 Infection" en ClinicalTrials.gov
Número do ensaio clínico NCT04299724 para "Safety and Immunity of Covid-19 aAPC Vaccine" en ClinicalTrials.gov
Número do ensaio clínico NCT04276896 para "Immunity and Safety of Covid-19 Synthetic Minigene Vaccine" en ClinicalTrials.gov
Número do ensaio clínico NCT04336410 para "Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers" en ClinicalTrials.gov

clinicaltrialsarena.com

Praveen Duddu (19 de febreiro de 2020). "Coronavirus outbreak: Vaccines/drugs in the pipeline for Covid-19". Clinical Trials Arena. Arquivado dende o orixinal o 19 de febreiro de 2020. Consultado o 19 de febreiro de 2020.

cmaj.ca

Cheng, Matthew P.; Lee, Todd C. Lee; Tan, Darrell H.S.; Murthy, Srinivas (26 de marzo de 2020). "Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic" (PDF). Canadian Medical Association Journal: cmaj.200438. ISSN 0820-3946. doi:10.1503/cmaj.200438. Consultado o 27 de marzo de 2020.

cnet.com

Shankland, Stephen. "Sixteen supercomputers tackle coronavirus cures in US". CNET (en inglés). Consultado o 2020-03-23.

cnn.com

Ziady, Hanna (26 de febreiro de 2020). "Biotech company Moderna says its coronavirus vaccine is ready for first tests". CNN. Arquivado dende o orixinal o 28 de febreiro de 2020. Consultado o 2 de marzo de 2020.
Yeung, Jessie (29 de marzo de 2020). "Millions of chickens are used to make vaccines each year. But that won't work for coronavirus". CNN. Consultado o 2020-04-04.

consalud.es

Consalud.es La primera vacuna española candidata a frenar el Covid-19, “antes del fin de abril”

ctvnews.ca

Cillian O'Brien (31 de marzo de 2020). "Vaccine watch: These are the efforts being made around the world". CTV News, Bell Media. Arquivado dende o orixinal o 24 de setembro de 2020. Consultado o 1 de abril de 2020.

defense.gov

"Defense Department Press Briefing Investigating and Developing Vaccine Candidates Against COVID-19 (Transcript)". Arlington, VA: United States Department of Defense. 5 de marzo de 2020. Consultado o 19 de marzo de 2020.

doi.org

dx.doi.org

Thanh Le, Tung; Andreadakis, Zacharias; Kumar, Arun; Gómez Román, Raúl; Tollefsen, Stig; Saville, Melanie; Mayhew, Stephen (9 de abril de 2020). "The COVID-19 vaccine development landscape". Nature Reviews Drug Discovery. ISSN 1474-1776. doi:10.1038/d41573-020-00073-5.
Cavanagh, Dave (2003). "Severe acute respiratory syndrome vaccine development: Experiences of vaccination against avian infectious bronchitis coronavirus". Avian Pathology 32 (6): 567–582. PMID 14676007. doi:10.1080/03079450310001621198.
Gao, Wentao; Tamin, Azaibi; Soloff, Adam; d'Aiuto, Leonardo; Nwanegbo, Edward; Robbins, Paul D.; Bellini, William J.; Barratt-Boyes, Simon; Gambotto, Andrea (2003). "Effects of a SARS-associated coronavirus vaccine in monkeys". The Lancet 362 (9399): 1895–1896. PMC 7112457. PMID 14667748. doi:10.1016/S0140-6736(03)14962-8.
Kim, Eun; Okada, Kaori; Kenniston, Tom; Raj, V. Stalin; Alhajri, Mohd M.; Farag, Elmoubasher A.B.A.; Alhajri, Farhoud; Osterhaus, Albert D.M.E.; Haagmans, Bart L.; Gambotto, Andrea (2014). "Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/C mice". Vaccine 32 (45): 5975–5982. PMC 7115510. PMID 25192975. doi:10.1016/j.vaccine.2014.08.058.
Jiang, Shibo; Lu, Lu; Du, Lanying (2013). "Development of SARS vaccines and therapeutics is still needed". Future Virology 8 (1): 1–2. PMC 7079997. PMID 32201503. doi:10.2217/fvl.12.126.
Greenough, Thomas C.; Babcock, Gregory J.; Roberts, Anjeanette; Hernandez, Hector J.; et al. (15 de febreiro de 2005). "Development and Characterization of a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in Mice". The Journal of Infectious Diseases 191 (4): 507–14. PMC 7110081. PMID 15655773. doi:10.1086/427242.
Tripp, Ralph A.; Haynes, Lia M.; Moore, Deborah; Anderson, Barbara; et al. (setembro de 2005). "Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins". Journal of Virological Methods 128 (1–2): 21–8. PMC 7112802. PMID 15885812. doi:10.1016/j.jviromet.2005.03.021.
Roberts, Anjeanette; Thomas, William D.; Guarner, Jeannette; Lamirande, Elaine W.; et al. (marfzo de 2006). "Therapy with a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody Reduces Disease Severity and Viral Burden in Golden Syrian Hamsters". The Journal of Infectious Diseases 193 (5): 685–92. PMC 7109703. PMID 16453264. doi:10.1086/500143.
Shehata, M.M., Gomaa, M.R., Ali, M.A. et al. Middle East respiratory syndrome coronavirus: a comprehensive review. Front. Med. 10, 120–136 (2016). doi 10.1007/s11684-016-0430-6
Butler, Declan (outubro de 2012). "SARS veterans tackle coronavirus". Nature 490 (7418): 20. Bibcode:2012Natur.490...20B. PMID 23038444. doi:10.1038/490020a.
Modjarrad, Kayvon; Roberts, Christine C.; Mills, Kristin T.; Castellano, Amy R.; Paolino, Kristopher; Muthumani, Kar; Reuschel, Emma L.; Robb, Merlin L.; Racine, Trina; Oh, Myoung-don; Lamarre, Claude; Zaidi, Faraz I.; Boyer, Jean; Kudchodkar, Sagar B.; Jeong, Moonsup; Darden, Janice M.; Park, Young K.; Scott, Paul T.; Remigio, Celine; Parikh, Ajay P.; Wise, Megan C.; Patel, Ami; Duperret, Elizabeth K.; Kim, Kevin Y.; Choi, Hyeree; White, Scott; Bagarazzi, Mark; May, Jeanine M.; Kane, Deborah; et al. (2019). "Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial.". The Lancet Infectious Diseases 19 (9): 1013–1022. PMID 31351922. doi:10.1016/S1473-3099(19)30266-X.
Yong, Chean Yeah; Ong, Hui Kian; Yeap, Swee Keong; Ho, Kok Lian; Tan, Wen Siang (2019). "Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus". Frontiers in Microbiology 10: 1781. PMC 6688523. PMID 31428074. doi:10.3389/fmicb.2019.01781.
Fauci, Anthony S.; Lane, H. Clifford; Redfield, Robert R. (28 de febreiro de 2020). "Covid-19 — Navigating the Uncharted". New England Journal of Medicine 382 (13): 1268–1269. ISSN 0028-4793. PMID 32109011. doi:10.1056/nejme2002387.
Gates, Bill (28 de febreiro de 2020). "Responding to Covid-19 — A Once-in-a-Century Pandemic?". New England Journal of Medicine. ISSN 0028-4793. PMID 32109012. doi:10.1056/nejmp2003762.
Cheng, Matthew P.; Lee, Todd C. Lee; Tan, Darrell H.S.; Murthy, Srinivas (26 de marzo de 2020). "Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic" (PDF). Canadian Medical Association Journal: cmaj.200438. ISSN 0820-3946. doi:10.1503/cmaj.200438. Consultado o 27 de marzo de 2020.
Kim, Eun; et al. (2 de abril de 2020). "Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development". EBioMedicine: 102743. doi:10.1016/j.ebiom.2020.102743. Consultado o 2 de abril de 2020.
Thorp, H. Holden (23 de marzo de 2020). "Underpromise, overdeliver" (PDF). Science (en inglés) (American Association for the Advancement of Science) 367 (6485): 1405. PMID 32205459. doi:10.1126/science.abb8492. Consultado o 23 de marzo de 2020.

europa.eu

ec.europa.eu

"Coronavirus: Commission offers financing to innovative vaccines company CureVac". European Commission. 16 de marzo de 2020. Consultado o 19 de marzo de 2020.

factcheck.org

McDonald, Jessica (24 de xaneiro de 2020). "Social Media Posts Spread Bogus Coronavirus Conspiracy Theory". FactCheck.org. Annenberg Public Policy Center. Arquivado dende o orixinal o 6 febreiro de 2020. Consultado o 8 febreiro de 2020.

fda.gov

"The drug development process". US Food and Drug Administration. 4 de xaneiro de 2018. Consultado o 12 de abril de 2020.

fiercepharma.com

Angus Liu (10 de abril de 2020). "China's CanSino Bio advances COVID-19 vaccine into phase 2 on preliminary safety data". FiercePharma (en inglés). Consultado o 2020-04-13.

globalnews.ca

Maham Abedi (23 de marzo de 2020). "Canada to spend $192M on developing COVID-19 vaccine". Global News. Consultado o 24 de marzo de 2020.

globenewswire.com

"Generex Provides Coronavirus Update: Generex Receives Contract from Chinese Partners to Develop a COVID-19 Vaccine Using Ii-Key Peptide Vaccines" (Nota de prensa). Generex. 2020-02-27. Arquivado dende o orixinal o 19 de agosto de 2020. Consultado o 2020-03-25.

harvard.edu

adsabs.harvard.edu

Butler, Declan (outubro de 2012). "SARS veterans tackle coronavirus". Nature 490 (7418): 20. Bibcode:2012Natur.490...20B. PMID 23038444. doi:10.1038/490020a.

imperial.ac.uk

Wilson, Joanna (2020-03-20). "In pictures: the Imperial lab developing a COVID-19 vaccine" (Nota de prensa). London: Imperial College London. Consultado o 2020-03-24.

indiatimes.com

economictimes.indiatimes.com

"Will take one-and-a-half to two years for India to develop vaccine for COVID-19: Health Ministry". Economic Times. 12 de marzo de 2020. Consultado o 12 de marzo de 2020.

marketwatch.com

Lee, Jaimy (1 de abril de 2020). "These nine companies are working on coronavirus treatments or vaccines — here's where things stand". MarketWatch. Consultado o 2 de abril de 2020.

milkeninstitute.org

"COVID-19 treatment and vaccine tracker" (PDF). Milken Institute. 9 de abril de 2020. Consultado o 9 de abril de 2020. Resumo divulgativo.

mybluemix.net

covid19-hpc.mybluemix.net

"Homepage of The COVID-19 High Performance Computing Consortium". Arquivado dende o orixinal o 28 de marzo de 2020. Consultado o 2020-03-28.

nasdaq.com

"Vaxart (VXRT) - A long shot or perfect shot?". NASDAQ, RTTNews.com. 25 de febreiro de 2020. Consultado o 1 de marzo de 2020.

nature.com

Thanh Le, Tung; Andreadakis, Zacharias; Kumar, Arun; Gómez Román, Raúl; Tollefsen, Stig; Saville, Melanie; Mayhew, Stephen (9 de abril de 2020). "The COVID-19 vaccine development landscape". Nature Reviews Drug Discovery. ISSN 1474-1776. doi:10.1038/d41573-020-00073-5.

nhs.uk

"SARS (severe acute respiratory syndrome)". National Health Service. 5 de marzo de 2020. Arquivado dende o orixinal o 9 de marzo de 2020. Consultado o 31 de xaneiro de 2020.

nih.gov

ncbi.nlm.nih.gov

Cavanagh, Dave (2003). "Severe acute respiratory syndrome vaccine development: Experiences of vaccination against avian infectious bronchitis coronavirus". Avian Pathology 32 (6): 567–582. PMID 14676007. doi:10.1080/03079450310001621198.
Gao, Wentao; Tamin, Azaibi; Soloff, Adam; d'Aiuto, Leonardo; Nwanegbo, Edward; Robbins, Paul D.; Bellini, William J.; Barratt-Boyes, Simon; Gambotto, Andrea (2003). "Effects of a SARS-associated coronavirus vaccine in monkeys". The Lancet 362 (9399): 1895–1896. PMC 7112457. PMID 14667748. doi:10.1016/S0140-6736(03)14962-8.
Kim, Eun; Okada, Kaori; Kenniston, Tom; Raj, V. Stalin; Alhajri, Mohd M.; Farag, Elmoubasher A.B.A.; Alhajri, Farhoud; Osterhaus, Albert D.M.E.; Haagmans, Bart L.; Gambotto, Andrea (2014). "Immunogenicity of an adenoviral-based Middle East Respiratory Syndrome coronavirus vaccine in BALB/C mice". Vaccine 32 (45): 5975–5982. PMC 7115510. PMID 25192975. doi:10.1016/j.vaccine.2014.08.058.
Jiang, Shibo; Lu, Lu; Du, Lanying (2013). "Development of SARS vaccines and therapeutics is still needed". Future Virology 8 (1): 1–2. PMC 7079997. PMID 32201503. doi:10.2217/fvl.12.126.
Greenough, Thomas C.; Babcock, Gregory J.; Roberts, Anjeanette; Hernandez, Hector J.; et al. (15 de febreiro de 2005). "Development and Characterization of a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in Mice". The Journal of Infectious Diseases 191 (4): 507–14. PMC 7110081. PMID 15655773. doi:10.1086/427242.
Tripp, Ralph A.; Haynes, Lia M.; Moore, Deborah; Anderson, Barbara; et al. (setembro de 2005). "Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): Identification of neutralizing and antibodies reactive to S, N, M and E viral proteins". Journal of Virological Methods 128 (1–2): 21–8. PMC 7112802. PMID 15885812. doi:10.1016/j.jviromet.2005.03.021.
Roberts, Anjeanette; Thomas, William D.; Guarner, Jeannette; Lamirande, Elaine W.; et al. (marfzo de 2006). "Therapy with a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody Reduces Disease Severity and Viral Burden in Golden Syrian Hamsters". The Journal of Infectious Diseases 193 (5): 685–92. PMC 7109703. PMID 16453264. doi:10.1086/500143.
Butler, Declan (outubro de 2012). "SARS veterans tackle coronavirus". Nature 490 (7418): 20. Bibcode:2012Natur.490...20B. PMID 23038444. doi:10.1038/490020a.
Modjarrad, Kayvon; Roberts, Christine C.; Mills, Kristin T.; Castellano, Amy R.; Paolino, Kristopher; Muthumani, Kar; Reuschel, Emma L.; Robb, Merlin L.; Racine, Trina; Oh, Myoung-don; Lamarre, Claude; Zaidi, Faraz I.; Boyer, Jean; Kudchodkar, Sagar B.; Jeong, Moonsup; Darden, Janice M.; Park, Young K.; Scott, Paul T.; Remigio, Celine; Parikh, Ajay P.; Wise, Megan C.; Patel, Ami; Duperret, Elizabeth K.; Kim, Kevin Y.; Choi, Hyeree; White, Scott; Bagarazzi, Mark; May, Jeanine M.; Kane, Deborah; et al. (2019). "Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial.". The Lancet Infectious Diseases 19 (9): 1013–1022. PMID 31351922. doi:10.1016/S1473-3099(19)30266-X.
Yong, Chean Yeah; Ong, Hui Kian; Yeap, Swee Keong; Ho, Kok Lian; Tan, Wen Siang (2019). "Recent Advances in the Vaccine Development Against Middle East Respiratory Syndrome-Coronavirus". Frontiers in Microbiology 10: 1781. PMC 6688523. PMID 31428074. doi:10.3389/fmicb.2019.01781.
Fauci, Anthony S.; Lane, H. Clifford; Redfield, Robert R. (28 de febreiro de 2020). "Covid-19 — Navigating the Uncharted". New England Journal of Medicine 382 (13): 1268–1269. ISSN 0028-4793. PMID 32109011. doi:10.1056/nejme2002387.
Gates, Bill (28 de febreiro de 2020). "Responding to Covid-19 — A Once-in-a-Century Pandemic?". New England Journal of Medicine. ISSN 0028-4793. PMID 32109012. doi:10.1056/nejmp2003762.
Thorp, H. Holden (23 de marzo de 2020). "Underpromise, overdeliver" (PDF). Science (en inglés) (American Association for the Advancement of Science) 367 (6485): 1405. PMID 32205459. doi:10.1126/science.abb8492. Consultado o 23 de marzo de 2020.

nih.gov

"NIH clinical trial of investigational vaccine for COVID-19 begins" (en inglés). US National Institutes of Health. 16 de marzo de 2020. Consultado o 17 de marzo de 2020.

nytimes.com

Broad, William (2020-03-26). "A.I. Versus the Coronavirus". The New York Times. Consultado o 2020-03-28.

politifact.com

Kertscher, Tom (23 de xaneiro de 2020). "No, there is no vaccine for the Wuhan coronavirus". PolitiFact. Poynter Institute. Arquivado dende o orixinal o 7 febreiro de 2020. Consultado o 7 febreiro de 2020.

preprints.org

Bojin, Florina; Gavriliuc, Oana; Margineanu, Michael-Bogdan; Paunescu, Virgil (2020-02-08). "Design of an Epitope-Based Synthetic Long Peptide Vaccine to Counteract the Novel China Coronavirus (2019-nCoV)" (en inglés).

reuters.com

Steenhuysen J, Kelland K (24 de xaneiro de 2020). "With Wuhan virus genetic code in hand, scientists begin work on a vaccine". Reuters. Arquivado dende o orixinal o 25 de xaneiro de 2020. Consultado o 25 de xaneiro de 2020.
Mishra, Manas (29 de xaneiro de 2020). Orr, Bernard; Kuber, Shailesh, eds. "Johnson & Johnson working on vaccine for deadly coronavirus". Reuters. Arquivado dende o orixinal o 29 de xaneiro de 2020. Consultado o 19 de febreiro de 2020.

romania-actualitati.ro

""Vaccin împotriva noului coronavirus", în teste la OncoGen Timișoara - România - Radio România Actualităţi Online". www.romania-actualitati.ro. Consultado o 2020-03-28.

sciencealert.com

Grenfell, Rob; Drew, Trevor (17de febreiro de 2020). "Here's Why It's Taking So Long to Develop a Vaccine for the New Coronavirus". ScienceAlertarchive-url=https://web.archive.org/web/20200228010631/https://www.sciencealert.com/who-says-a-coronavirus-vaccine-is-18-months-away. Consultado o 26 de febreiro de 2020.

sciencemag.org

science.sciencemag.org

Thorp, H. Holden (23 de marzo de 2020). "Underpromise, overdeliver" (PDF). Science (en inglés) (American Association for the Advancement of Science) 367 (6485): 1405. PMID 32205459. doi:10.1126/science.abb8492. Consultado o 23 de marzo de 2020.

scmp.com

Jeong-ho, Lee; Zheng, William; Zhou, Laura (26 xaneiro de 2020). "Chinese scientists race to develop vaccine as coronavirus death toll jumps". South China Morning Post. Arquivado dende o orixinal o 26 de xaneiro de 2020. Consultado o 28 de xaneiro de 2020.
Cheung, Elizabeth (28 de xaneiro de 2020). "Hong Kong researchers have developed coronavirus vaccine, expert reveals". South China Morning Post. Arquivado dende o orixinal o 28 de xaneiro de 2020. Consultado o 28 de xaneiro de 2020.

shelstonip.com

"COVID-19: mRNA vaccines – a promising approach to vaccine development". Shelston IP Australia – Intellectual Property & Patent Services | IP Attorneys & IP Lawyers (en inglés). 2020-03-23. Arquivado dende o orixinal o 09 de abril de 2020. Consultado o 2020-03-23.

springer.com

link.springer.com

Shehata, M.M., Gomaa, M.R., Ali, M.A. et al. Middle East respiratory syndrome coronavirus: a comprehensive review. Front. Med. 10, 120–136 (2016). doi 10.1007/s11684-016-0430-6

stlpublicradio.org

news.stlpublicradio.org

Chen, Eli (5 de marzo de 2020). "Wash U Scientists Are Developing A Coronavirus Vaccine". news.stlpublicradio.org (en inglés). Consultado o 19 de marzo de 2020.

takisbiotech.it

"Takis, a biotech company in Castel Romano, Rome, announced that it is ready to test its COVID-19 vaccine on pre-clinical models." (PDF) (Nota de prensa). Rome: Takis Biotech. 2020-03-17. Consultado o 2020-03-24.

techcrunch.com

"Pfizer and BioNTech announce joint development of a potential COVID-19 vaccine". TechCrunch. 18 de marzo de 2020. Consultado o 18 de marzo de 2020.

theguardian.com

Spinney, Laura (18 de marzo de 2020). "When will a coronavirus vaccine be ready?". The Guardian. Consultado o 18 de marzo de 2020.
Devlin, Hannah (24 de xaneiro de 2020). "Lessons from SARS outbreak help in race for coronavirus vaccine". The Guardian. Arquivado dende o orixinal o 25 de xaneiro de 2020. Consultado o 25 de xaneiro de 2020.
Oltermann, Philip (15 de marzo de 2020). "Trump 'offers large sums' for exclusive access to coronavirus vaccine". The Guardian.

thelancet.com

Kim, Eun; et al. (2 de abril de 2020). "Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development". EBioMedicine: 102743. doi:10.1016/j.ebiom.2020.102743. Consultado o 2 de abril de 2020.

trialsitenews.com

"University of Oxford commences clinical trial for vaccine candidate (ChAdOx1 nCoV-19) Targeting COVID-19". Trial Site News (en inglés). 31 de marzo de 2020. Consultado o 13 de abril de 2020.

triblive.com

Martines, Jamie (2 de abril de 2020). "Pittsburgh scientists develop possible coronavirus vaccine, hope FDA can fast-track it". Pittsburgh Tribune-Review. Consultado o 2 de abril de 2020.

usnews.com

Andrew Osborn (20 de marzo de 2020). "Russia starts testing coronavirus vaccine prototypes on animals". U.S. News & World Report. Thomson Reuters. Consultado o 2020-03-21.

vaccines.gov

"Vaccine Safety - Vaccines". www.vaccines.gov. US Department of Health and Human Services. Consultado o 13 de abril de 2020.

web.archive.org

Grenfell, Rob; Drew, Trevor (17de febreiro de 2020). "Here's Why It's Taking So Long to Develop a Vaccine for the New Coronavirus". ScienceAlertarchive-url=https://web.archive.org/web/20200228010631/https://www.sciencealert.com/who-says-a-coronavirus-vaccine-is-18-months-away. Consultado o 26 de febreiro de 2020.
"SARS (severe acute respiratory syndrome)". National Health Service. 5 de marzo de 2020. Arquivado dende o orixinal o 9 de marzo de 2020. Consultado o 31 de xaneiro de 2020.
Steenhuysen J, Kelland K (24 de xaneiro de 2020). "With Wuhan virus genetic code in hand, scientists begin work on a vaccine". Reuters. Arquivado dende o orixinal o 25 de xaneiro de 2020. Consultado o 25 de xaneiro de 2020.
Praveen Duddu (19 de febreiro de 2020). "Coronavirus outbreak: Vaccines/drugs in the pipeline for Covid-19". Clinical Trials Arena. Arquivado dende o orixinal o 19 de febreiro de 2020. Consultado o 19 de febreiro de 2020.
Cillian O'Brien (31 de marzo de 2020). "Vaccine watch: These are the efforts being made around the world". CTV News, Bell Media. Arquivado dende o orixinal o 24 de setembro de 2020. Consultado o 1 de abril de 2020.
Ziady, Hanna (26 de febreiro de 2020). "Biotech company Moderna says its coronavirus vaccine is ready for first tests". CNN. Arquivado dende o orixinal o 28 de febreiro de 2020. Consultado o 2 de marzo de 2020.
Devlin, Hannah (24 de xaneiro de 2020). "Lessons from SARS outbreak help in race for coronavirus vaccine". The Guardian. Arquivado dende o orixinal o 25 de xaneiro de 2020. Consultado o 25 de xaneiro de 2020.
"Clinical Development Success Rates 2006-2015" (PDF). BIO Industry Analysis. xuño de 2016. Arquivado dende o orixinal (PDF) o 12 de setembro de 2019. Consultado o 06 de abril de 2020.
Jeong-ho, Lee; Zheng, William; Zhou, Laura (26 xaneiro de 2020). "Chinese scientists race to develop vaccine as coronavirus death toll jumps". South China Morning Post. Arquivado dende o orixinal o 26 de xaneiro de 2020. Consultado o 28 de xaneiro de 2020.
Cheung, Elizabeth (28 de xaneiro de 2020). "Hong Kong researchers have developed coronavirus vaccine, expert reveals". South China Morning Post. Arquivado dende o orixinal o 28 de xaneiro de 2020. Consultado o 28 de xaneiro de 2020.
Mishra, Manas (29 de xaneiro de 2020). Orr, Bernard; Kuber, Shailesh, eds. "Johnson & Johnson working on vaccine for deadly coronavirus". Reuters. Arquivado dende o orixinal o 29 de xaneiro de 2020. Consultado o 19 de febreiro de 2020.
"Generex Provides Coronavirus Update: Generex Receives Contract from Chinese Partners to Develop a COVID-19 Vaccine Using Ii-Key Peptide Vaccines" (Nota de prensa). Generex. 2020-02-27. Arquivado dende o orixinal o 19 de agosto de 2020. Consultado o 2020-03-25.
"COVID-19: mRNA vaccines – a promising approach to vaccine development". Shelston IP Australia – Intellectual Property & Patent Services | IP Attorneys & IP Lawyers (en inglés). 2020-03-23. Arquivado dende o orixinal o 09 de abril de 2020. Consultado o 2020-03-23.
"Homepage of The COVID-19 High Performance Computing Consortium". Arquivado dende o orixinal o 28 de marzo de 2020. Consultado o 2020-03-28.
Kertscher, Tom (23 de xaneiro de 2020). "No, there is no vaccine for the Wuhan coronavirus". PolitiFact. Poynter Institute. Arquivado dende o orixinal o 7 febreiro de 2020. Consultado o 7 febreiro de 2020.
McDonald, Jessica (24 de xaneiro de 2020). "Social Media Posts Spread Bogus Coronavirus Conspiracy Theory". FactCheck.org. Annenberg Public Policy Center. Arquivado dende o orixinal o 6 febreiro de 2020. Consultado o 8 febreiro de 2020.

worldcat.org

Thanh Le, Tung; Andreadakis, Zacharias; Kumar, Arun; Gómez Román, Raúl; Tollefsen, Stig; Saville, Melanie; Mayhew, Stephen (9 de abril de 2020). "The COVID-19 vaccine development landscape". Nature Reviews Drug Discovery. ISSN 1474-1776. doi:10.1038/d41573-020-00073-5.
Fauci, Anthony S.; Lane, H. Clifford; Redfield, Robert R. (28 de febreiro de 2020). "Covid-19 — Navigating the Uncharted". New England Journal of Medicine 382 (13): 1268–1269. ISSN 0028-4793. PMID 32109011. doi:10.1056/nejme2002387.
Gates, Bill (28 de febreiro de 2020). "Responding to Covid-19 — A Once-in-a-Century Pandemic?". New England Journal of Medicine. ISSN 0028-4793. PMID 32109012. doi:10.1056/nejmp2003762.
Cheng, Matthew P.; Lee, Todd C. Lee; Tan, Darrell H.S.; Murthy, Srinivas (26 de marzo de 2020). "Generating randomized trial evidence to optimize treatment in the COVID-19 pandemic" (PDF). Canadian Medical Association Journal: cmaj.200438. ISSN 0820-3946. doi:10.1503/cmaj.200438. Consultado o 27 de marzo de 2020.